Formulations of blood clot-polymer matrix for delivery of osteogenic proteins
US5171579A · kind A · utility
81Cited by
7References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 11, 1991 |
| Grant date | Dec 15, 1992 |
| Priority date | — |
| Expiry date | Oct 11, 2011 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A composition comprising a pharmaceutically acceptable admixture of an osteogenic protein; a porous particulate polymer matrix; and an osteogenic protein-sequestering amount of blood clot.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.